or Try an Advanced Search...

    Technical Analysis for OGN - Organon & Co.

    Grade Last Price % Change Price Change
    C 20.31 -1.88% -0.39
    OGN closed down 1.88 percent on Monday, July 1, 2024, on 81 percent of normal volume. The stock fell below its 50 day moving average, damaging its intermediate-term outlook by crossing under that important trendline.
    2 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Up Flat Down
    Historical OGN trend table...
    Date Alert Name Type % Chg
    20 DMA Resistance Bearish 0.00%
    Fell Below 50 DMA Bearish 0.00%
    Expansion Pivot Sell Setup Bearish Swing Setup 0.00%
    Bollinger Band Squeeze Range Contraction 0.00%
    20 DMA Resistance Bearish -1.88%
    Pocket Pivot Bullish Swing Setup -1.88%
    Bollinger Band Squeeze Range Contraction -1.88%
    Gapped Up Strength -1.88%
    Bollinger Band Squeeze Range Contraction -1.36%
    Down 3 Days in a Row Weakness -1.36%
    Older End-of-Day Signals for OGN ...

       Recent Intraday Alerts

    Alert Time
    50 DMA Support about 4 hours ago
    Down 1 ATR about 5 hours ago
    Fell Below 50 DMA about 5 hours ago
    Down 2 % about 5 hours ago
    Down 1% about 8 hours ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    OGN Chart by TradingView
    Basic chart:

    Profile

    Organon & Co., a science-based pharmaceutical company, develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. Organon & Co. was incorporated in 2020 and is based in Jersey City, New Jersey. Organon & Co. operates independently of Merck & Co., Inc. as of June 2, 2021.
    Classification
    Sector: Healthcare
    Industry: Drug Manufacturers - General
    Keywords: Life Sciences Pharmaceutical Health Care Health Solutions Biosimilar Science Based Pharmaceutical

    Is OGN a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 1 bullish, 0 bearish and 4 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Jun 28 Do Options Traders Know Something About Organon (OGN) Stock We Don't?
    Jun 3 Organon (OGN) Just Overtook the 20-Day Moving Average
    May 24 European Medicines Agency (EMA) Validates Henlius and Organon Filings for Prolia® and Xgeva® (denosumab) Biosimilar Candidate HLX14
    May 11 Organon Graduates From Spinoff Skepticism, With A Yield Above 5%
    May 8 Organon Q1 Earnings: Does The $1 Billion Debt Offering Signal Trouble?
    May 8 Organon announces pricing of $1 billion senior notes offering
    May 8 Organon Announces Pricing of $1.0 Billion Senior Notes Offering
    May 7 Four Reasons Why Organon Stock Is A Good Buy
    May 7 Organon plans to offer $1B in senior notes
    May 7 Organon Announces Proposed $1.0 Billion Senior Notes Offering
    See more OGN news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 22.538
    52 Week Low 10.5258
    Average Volume 1,834,207
    200-Day Moving Average 16.59
    50-Day Moving Average 20.33
    20-Day Moving Average 20.67
    10-Day Moving Average 20.61
    Average True Range 0.53
    RSI (14) 45.36
    ADX 15.7
    +DI 24.20
    -DI 23.49
    Chandelier Exit (Long, 3 ATRs) 20.20
    Chandelier Exit (Short, 3 ATRs) 21.40
    Upper Bollinger Bands 21.24
    Lower Bollinger Band 20.11
    Percent B (%b) 0.18
    BandWidth 5.43
    MACD Line 0.03
    MACD Signal Line 0.09
    MACD Histogram -0.0615
    Fundamentals Value
    Market Cap 5.19 Billion
    Num Shares 256 Million
    EPS 2.28
    Price-to-Earnings (P/E) Ratio 8.91
    Price-to-Sales 0.68
    Price-to-Book 1.84
    Dividend 1.12
    Dividend Yield 5.51%
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 21.57
    Resistance 3 (R3) 21.66 21.34 21.36
    Resistance 2 (R2) 21.34 21.02 21.29 21.29
    Resistance 1 (R1) 20.82 20.82 20.66 20.73 21.22
    Pivot Point 20.50 20.50 20.42 20.45 20.50
    Support 1 (S1) 19.98 20.18 19.82 19.89 19.40
    Support 2 (S2) 19.66 19.98 19.61 19.33
    Support 3 (S3) 19.14 19.66 19.26
    Support 4 (S4) 19.05